{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Edgewise Therapeutics, Inc."},"Symbol":{"label":"Symbol","value":"EWTX"},"Address":{"label":"Address","value":"1715 38TH ST, BOULDER, Colorado, 80301, United States"},"Phone":{"label":"Phone","value":"+1 720 262-7002"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases."},"CompanyUrl":{"label":"Company Url","value":"https://www.edgewisetx.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Alan Russell","title":"Director & Chief Scientific Officer"},{"name":"Joanne M. Donovan","title":"Chief Medical Officer"},{"name":"Kevin Koch","title":"President, Chief Executive Officer & Director"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}